$TBPH Theravance Biopharma, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Theravance Biopharma, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Theravance Biopharma, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Theravance Biopharma, Inc. for free.

CIK Number: 0001583107
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: TBPH
Company Address: UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN KY1-1104

Theravance Biopharma, Inc. operates as a biopharmaceutical company, which focuses on the discovery, development and commercialization of small molecule medicines. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.

Market Capitalization: $1.64B
Prev close: $30.60
Average Daily Volume: 346,635
Days Low: $30.63
Year Low: $13.59
Year High: $38.92

Theravance Biopharma, Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
GALA RENEE DSVP, Chief Financial Officer164,3545,029,232shares bought: 132,750 / shares sold: -129,791 BUYAug 22 20183 months ago
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc142,2794,353,737shares bought: 132,750 / shares sold: -120,979 BUYAug 22 20183 months ago
HEGDE SHARATHCHANDRA SSVP, Research169,0605,173,236shares bought: 147,750 / shares sold: -59,855 STRONG BUYAug 22 20183 months ago
PASQUALONE FRANKSVP, Chief Comm Ops Officer222,0756,795,495shares bought: 136,750 / shares sold: -55,122 STRONG BUYAug 22 20183 months ago
PITZER KENNETH RSVP, Prod Strat & Comm Plng161,9824,956,649shares bought: 156,750 / shares sold: -58,329 STRONG BUYAug 22 20183 months ago
Shafer Bradford JEVP, Gen. Counsel, Secretary84,0002,570,400shares bought: 166,750 / shares sold: -223,185 SELLAug 29 20183 months ago
Winningham Rick EChief Executive Officer904,06327,664,328shares bought: 451,000 / shares sold: -153,263 STRONG BUYAug 22 20183 months ago
WORBOYS PHILIP DSVP, Translational Science166,7535,102,642shares bought: 156,750 / shares sold: -69,209 STRONG BUYSep 14 20182 months ago

View all Theravance Biopharma, Inc. insiders.

Theravance Biopharma, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 14 2018TBPHTheravance Biophar ...WORBOYS PHILIP DSVP, Translational ...SellS28.506,393182,201166,753173.1 K to 166.8 K (-3.69 %)
Aug 29 2018TBPHTheravance Biophar ...Shafer Bradford JEVP, Gen. Counsel, ...SellS27.717,119197,28284,00091.1 K to 84 K (-7.81 %)
Aug 22 2018TBPHTheravance Biophar ...WORBOYS PHILIP DSVP, Translational ...Payment of ExerciseF26.955,508148,441173,146178.7 K to 173.1 K (-3.08 %)
Aug 22 2018TBPHTheravance Biophar ...Winningham Rick EChief Executive Off ...Payment of ExerciseF26.9515,557419,261904,063919.6 K to 904.1 K (-1.69 %)
Aug 22 2018TBPHTheravance Biophar ...Shafer Bradford JEVP, Gen. Counsel, ...Payment of ExerciseF26.957,005188,78591,11998.1 K to 91.1 K (-7.14 %)
Aug 22 2018TBPHTheravance Biophar ...PITZER KENNETH RSVP, Prod Strat & C ...Payment of ExerciseF26.955,043135,909161,982167 K to 162 K (-3.02 %)
Aug 22 2018TBPHTheravance Biophar ...PASQUALONE FRANKSVP, Chief Comm Ops ...Payment of ExerciseF26.955,735154,558222,075227.8 K to 222.1 K (-2.52 %)
Aug 22 2018TBPHTheravance Biophar ...HEGDE SHARATHCHANDRA SSVP, ResearchPayment of ExerciseF26.955,198140,086169,060174.3 K to 169.1 K (-2.98 %)
Aug 22 2018TBPHTheravance Biophar ...HAUMANN BRETT KSVP Clin Dev & Chie ...Payment of ExerciseF26.956,683180,107142,279149 K to 142.3 K (-4.49 %)
Aug 22 2018TBPHTheravance Biophar ...GALA RENEE DSVP, Chief Financia ...Payment of ExerciseF26.956,695180,430164,354171 K to 164.4 K (-3.91 %)
Aug 16 2018TBPHTheravance Biophar ...GALA RENEE DSVP, Chief Financia ...SellS27.431,70046,623171,049172.7 K to 171 K (-0.98 %)
Aug 16 2018TBPHTheravance Biophar ...GALA RENEE DSVP, Chief Financia ...SellS26.7139,8391,064,032172,749212.6 K to 172.7 K (-18.74 %)
Aug 16 2018TBPHTheravance Biophar ...GALA RENEE DSVP, Chief Financia ...SellS27.742,20461,136212,588214.8 K to 212.6 K (-1.03 %)
Aug 09 2018TBPHTheravance Biophar ...Shafer Bradford JEVP, Gen. Counsel, ...SellS27.8525,355706,18298,124123.5 K to 98.1 K (-20.53 %)
Aug 09 2018TBPHTheravance Biophar ...Shafer Bradford JEVP, Gen. Counsel, ...SellS28.034,127115,686123,479127.6 K to 123.5 K (-3.23 %)

View all Theravance Biopharma, Inc. insider transactions.